Internal Medicine, Endocrinology, Diabetes, & Metabolism · Scottsdale, AZ
NPI
1679564512
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
9336 E Raintree Dr, Ste150
Scottsdale, AZ, 85260
Phone (480) 219-5597
Medicare paid, 2022
$76K
1,046 services
Medicare patients, 2022
454
Average age 73
Drug cost, 2024
$397K
908 prescriptions
Company payments, 2025
$2,657
From 31 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Grace Zlaket Matta was code 99214 (office e&m - established), 637 times for 351 patients. In total Grace Zlaket Matta billed 1,046 services in 12 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 637 | 351 | $81.10 | $52K |
| 95251 Test - Miscellaneous | Office | 124 | 54 | $25.68 | $3,184 |
| 99213 Office E&M - Established | Office | 120 | 110 | $51.82 | $6,219 |
| 99204 Office E&M - New | Office | 51 | 51 | $116.89 | $5,961 |
| 76536 Ultrasound - Nonspecific | Office | 40 | 32 | $69.23 | $2,769 |
| 99203 Office E&M - New | Office | 33 | 33 | $71.76 | $2,368 |
| 99215 Office E&M - Established | Office | 20 | 17 | $131.94 | $2,639 |
Medicare prescription drug claims, 2024
In 2024, the drug Grace Zlaket Matta prescribed most often to Medicare patients was Levothyroxine Sodium, with 132 prescriptions and refills. In total Grace Zlaket Matta wrote 908 Medicare prescriptions that cost $397K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 132 | 352 | 49 | $1,186 |
| Ozempic Semaglutide | 73 | 87 | 22 | $80K |
| Atorvastatin Calcium Generic | 48 | 133 | 21 | $363 |
| Synthroid Levothyroxine Sodium | 43 | 109 | 16 | $3,926 |
| Mounjaro Tirzepatide | 36 | 41 | Under 11 | $38K |
| Metformin Hcl Er Metformin Hcl | 35 | 83 | 11 | $540 |
| Alendronate Sodium Generic | 35 | 97 | 12 | $359 |
| Liothyronine Sodium Generic | 30 | 55 | Under 11 | $496 |
| Ezetimibe Generic | 30 | 84 | 12 | $2,076 |
| Rosuvastatin Calcium Generic | 22 | 64 | Under 11 | $150 |
| Losartan Potassium Generic | 19 | 57 | Under 11 | $248 |
| Jardiance Empagliflozin | 19 | 47 | Under 11 | $25K |
| Trulicity Dulaglutide | 17 | 24 | Under 11 | $24K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 16 | 38 | Under 11 | $2,474 |
| Lisinopril Generic | 15 | 43 | Under 11 | $17.67 |
Brand drugs: 431 claims; generic drugs: 420 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Grace Zlaket Matta $2,657 ($2,657 in general payments such as food, travel and fees) from 31 companies. The largest payer was Corcept Therapeutics with $392.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 9 | $392 |
| Novo Nordisk Inc NVO | 22 | $228 |
| Lilly USA, LLC LLY | 13 | $200 |
| Abbott Laboratories ABT | 9 | $194 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $171 |
| Tandem Diabetes Care, Inc. TNDM | 8 | $153 |
| Sanofi-Aventis U.S. LLC SNY | 5 | $145 |
| Abbvie Inc. ABBV | 8 | $136 |
| Sequel Med Tech, LLC | 3 | $132 |
| Recordati_rare_diseases_inc. | 5 | $104 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.